LTR Pharma Limited (ASX:LTP) Secures A$25 Million Placement
LTR Pharma Limited secures A$25 million to advance its SPONTAN® treatment through regulatory processes in the U.S. market.
The Hub of Australian Finance News
LTR Pharma Limited secures A$25 million to advance its SPONTAN® treatment through regulatory processes in the U.S. market.
Visioneering Technologies, Inc. (ASX:VTI) has announced its intent to voluntarily delist from the ASX, seeking shareholder approval for the move.
29Metals Limited (ASX:29M) launches a retail entitlement offer aiming to raise approximately $36.2 million as part of a $180 million capital raise.
Transurban Group (ASX:TCL) declares a 32.0-cent distribution and reaffirms its FY25 guidance amidst notable traffic growth.
Develop Global Limited finalises a loan facility with Trafigura and is progressing towards the re-start of the Woodlawn Copper-Zinc Mine.
Terrain Minerals Limited has commenced drilling at its Wildflower Gold Project, aiming to explore newly identified mineral zones.
Novatti Group Limited (ASX:NOV) completes capital raising, securing $2 million to drive growth strategies and enhance financial performance.
Audio Pixels Holdings Limited secures A$1 million funding through a convertible note to enhance capital management efforts.
Strata Minerals Limited (ASX:SMX) announces major advancements in gold, uranium, and rare earths exploration projects.
Cobalt Blue Holdings (ASX:COB) and Mount Isa City Council sign an MOU to address the looming sulphuric acid supply shortage in North West Queensland.